<p>A. Each of twenty-seven peptides that covered the full length of the F1-antigen were used to coat an ELISA plate (0.05 ml of a 25 µg/ml solution of each peptide), and binding by the human anti-F1 m252 mAb (0.05 ml of a 10 µg/ml solution) was analyzed. The sample labeled F1 was the full-length antigen used to coat the plate as the positive control (0.05 ml of a 2 µg/ml solution), and the sample labeled Media was the negative control with no primary antibody added. B and C. Each of fifty-two peptides that covered the full length of the V- antigen was used to coat an ELISA plate (0.05 ml of a 25 µg/ml solution), and the human anti-V m253 (B) and m254 (C) mAbs were used (0.05 ml of a 10 µg/ml solution), respectively, to analyze for binding. ...
<p>(A) Epitope binning with the newly generated mAbs on post-fusion RSV A2 F protein revealed the mA...
<p>Peptide-ELISA format was used in covering all VP1, VP2, VP3 and VP4 sequences of CVA16.</p
(A) Epitope binning for mAbs binding to RSF F710 post-fusion. Antibody cross-competition was determi...
<p>A and B, Fab anti-V m253 and m254 binding to the V-antigen were analysed by competitions with equ...
<p>A. Anti-F1 human antibody m252 and anti-V human antibodies m253 and m254 were expressed as Fabs, ...
<p>(A) Schematic representation of peptides used for scanning the binding sites of anti-MPER. (B) Re...
<p>Six different peptide arrays (A–F) were used for mapping three antibodies each (Ab1–Ab3) generate...
The aim of this chapter is to provide a strategy for mapping linear antibody epitopes of protein ant...
<p>(A) Mapping of immunodominant B-cell linear epitopes within the VP1 protein. The pooled anti-VLP ...
<p>(A) Eleven BSA-conjugated peptides (spanning residues 515–558, 550–565, 563–600, 598–631, 618–641...
A continuous series of TH E2 12-mer peptides (peptide Nos. 1 to 82), staggered by 3 amino acids each...
<p>Biotin-linked peptides containing the 1H8 binding site and the specific mutation of the binding s...
The protein conjugates of two peptides (P1 and P2) with the sequences 101-116 and 253-274 of the hum...
This book: Epitope Mapping covers all the major methods for the identification and definition of epi...
Antibodies play an important role in the natural immune response to invading pathogens. The strong a...
<p>(A) Epitope binning with the newly generated mAbs on post-fusion RSV A2 F protein revealed the mA...
<p>Peptide-ELISA format was used in covering all VP1, VP2, VP3 and VP4 sequences of CVA16.</p
(A) Epitope binning for mAbs binding to RSF F710 post-fusion. Antibody cross-competition was determi...
<p>A and B, Fab anti-V m253 and m254 binding to the V-antigen were analysed by competitions with equ...
<p>A. Anti-F1 human antibody m252 and anti-V human antibodies m253 and m254 were expressed as Fabs, ...
<p>(A) Schematic representation of peptides used for scanning the binding sites of anti-MPER. (B) Re...
<p>Six different peptide arrays (A–F) were used for mapping three antibodies each (Ab1–Ab3) generate...
The aim of this chapter is to provide a strategy for mapping linear antibody epitopes of protein ant...
<p>(A) Mapping of immunodominant B-cell linear epitopes within the VP1 protein. The pooled anti-VLP ...
<p>(A) Eleven BSA-conjugated peptides (spanning residues 515–558, 550–565, 563–600, 598–631, 618–641...
A continuous series of TH E2 12-mer peptides (peptide Nos. 1 to 82), staggered by 3 amino acids each...
<p>Biotin-linked peptides containing the 1H8 binding site and the specific mutation of the binding s...
The protein conjugates of two peptides (P1 and P2) with the sequences 101-116 and 253-274 of the hum...
This book: Epitope Mapping covers all the major methods for the identification and definition of epi...
Antibodies play an important role in the natural immune response to invading pathogens. The strong a...
<p>(A) Epitope binning with the newly generated mAbs on post-fusion RSV A2 F protein revealed the mA...
<p>Peptide-ELISA format was used in covering all VP1, VP2, VP3 and VP4 sequences of CVA16.</p
(A) Epitope binning for mAbs binding to RSF F710 post-fusion. Antibody cross-competition was determi...